What is the primary driver of CME Group's revenue growth in this filing period?

The primary driver of CME Group's revenue growth is the increase in clearing and transaction fees, which are directly correlated with higher contract volumes. Additionally, revenue from market data and information services has shown robust growth, indicating increased demand for the company's data products.

How is CME Group managing its expenses?

CME Group's total expenses increased by 5% for the quarter and 6% for the nine months. While some expenses like technology and licensing fees have increased, likely due to investments in transformation projects and higher volumes, the company has seen a decrease in professional fees and outside services, and legal fees. Overall, operating expenses are growing at a slower pace than revenues, contributing to a strong operating margin.

What is the company's stance on its financial condition and liquidity?

CME Group's financial condition appears strong. Net cash provided by operating activities increased year-over-year, and the company maintains significant liquidity through its substantial cash and cash equivalents and credit facilities. The company also continues to return capital to shareholders through its share repurchase program and pays dividends.

What are the key risks highlighted by the company in this report?

While this specific 10-Q doesn't detail new risks, it refers to the Annual Report on Form 10-K for a comprehensive discussion. Generally, CME Group faces risks related to competition, technological advancements, regulatory changes, market volatility, and cybersecurity. The 'Forward-Looking Statements' section also outlines various factors that could impact future performance, such as evolving market conditions and global economic uncertainties.

CME 10-Q Quarterly Report Q3 FY2026 — Revenue, Net Income, EPS

01—Abstract

Summary

Summary of the 10-Q filed October 23, 2026. Cited figures are marked; the original filing is the authoritative source.

CME Group Inc. reported strong financial results for the nine months ended September 30, 2026, with total revenues increasing by 9% to $5.32 billion^a and net income growing by 12% to $3.23 billion compared to the same period in 2025.

This growth was driven by a 12%^b increase in contract volume, particularly in interest rate and equity index products, and a 19% rise in market data and information services revenue. The company maintained a healthy operating margin of 66.8% for the nine-month period. Despite a slight decrease in the average rate per contract, the significant increase in trading volumes across key asset classes, including interest rates, equity indexes, energy, and agriculture, underscores the company's ability to capitalize on market volatility and geopolitical events.

The balance sheet remains robust, with significant performance bond and guaranty fund contributions acting as a strong asset base. CME Group also continues to actively return capital to shareholders through its share repurchase program, having repurchased $1.8 billion^c year-to-date.

02—Key points

Key Highlights

Total revenues increased by 13% to $1.74 billion for the quarter ended September 30, 2026, and by 9% to $5.32 billion for the nine months ended September 30, 2026, year-over-year.
Net income grew by 14% to $1.04 billion for the quarter and by 12% to $3.23 billion for the nine months, demonstrating strong profitability.
Clearing and transaction fees rose by 12% to $1.38 billion for the quarter and 8% to $4.27 billion for the nine months, driven by a 16% increase in contract volume for the quarter and 12% for the nine months.
Market data and information services revenue saw a significant increase of 20% to $243.1 million for the quarter and 19% to $705.3 million for the nine months.
Operating margin remained strong at 65.7% for the quarter and 66.8% for the nine months.
Diluted earnings per common share increased by 16% to $2.89 for the quarter and 13% to $8.96 for the nine months.
The company repurchased $1.8 billion of Class A common stock in the first nine months of 2026 under its $3.0 billion repurchase program, with $1.0 billion remaining authorization.

03—Questions

Frequently Asked Questions

What is the primary driver of CME Group's revenue growth in this filing period?
The primary driver of CME Group's revenue growth is the increase in clearing and transaction fees, which are directly correlated with higher contract volumes. Additionally, revenue from market data and information services has shown robust growth, indicating increased demand for the company's data products.
How is CME Group managing its expenses?
CME Group's total expenses increased by 5% for the quarter and 6% for the nine months. While some expenses like technology and licensing fees have increased, likely due to investments in transformation projects and higher volumes, the company has seen a decrease in professional fees and outside services, and legal fees. Overall, operating expenses are growing at a slower pace than revenues, contributing to a strong operating margin.
What is the company's stance on its financial condition and liquidity?
CME Group's financial condition appears strong. Net cash provided by operating activities increased year-over-year, and the company maintains significant liquidity through its substantial cash and cash equivalents and credit facilities. The company also continues to return capital to shareholders through its share repurchase program and pays dividends.
What are the key risks highlighted by the company in this report?
While this specific 10-Q doesn't detail new risks, it refers to the Annual Report on Form 10-K for a comprehensive discussion. Generally, CME Group faces risks related to competition, technological advancements, regulatory changes, market volatility, and cybersecurity. The 'Forward-Looking Statements' section also outlines various factors that could impact future performance, such as evolving market conditions and global economic uncertainties.

04—Continue

← View all 10-Q filings